| Literature DB >> 34106397 |
Gabriele Savioli1,2, Iride Francesca Ceresa1, Viola Novelli3, Giovanni Ricevuti4, Maria Antonietta Bressan1, Enrico Oddone5.
Abstract
The geriatric population constitutes a large slice of the population of Western countries and a class of fragile patients, with greater deaths due to COVID-19. The patterns of healthcare utilization change during pandemic disease outbreaks. Identifying the patterns of changes of this particular fragile subpopulation is important for future preparedness and response. Overcrowding in the emergency department (ED) can occur because of the volume of patients waiting to be seen, delays in patient assessment or treatment in the ED, or impediments to leaving the ED once the treatment has been completed. Overcrowding has become a serious and growing issue globally, which represents a serious impediment to healthcare utilization. To estimate the rate of ED visits attributable to the outbreak and guide the planning of strategies for managing ED access or after the outbreak of transmittable respiratory diseases. This observational study was based on a retrospective review of the epidemiological and clinical records of patients aged > 75 years who visited the Foundation IRCCS Policlinic San Matteo during the first wave of COVID-19 outbreak (February 21 to May 1, 2020; pandemic group). The analysis methods included estimation of the changes in the epidemiological and clinical data from the annual baseline data after the start of the COVID-19 pandemic. Outcome measures and analysis: Primary objective is the evaluation of ED admission rate change and ED overcrowding. Secondary objectives are the evaluation of modes of ED access by reason and triage code, access types, clinical outcomes (such as admission and mortality rates). During the pandemic, ED crowding increased dramatically, although the overall number of patients decreased, in the face of a percentage increase in those with high-acuity conditions, because of changes in patient management that have prolonged length of stay (LOS) and increased rates of access block. Overcrowding during the COVID-19 pandemic can be attributed to the Access Block. Access Block solutions are hence required to prevent a recurrence of crowding to any new viral wave or new epidemic in the future.Entities:
Keywords: Access block; Coronavirus disease; Crowding; Emergency care utilization; Emergency department; Exit block; Pandemic
Mesh:
Year: 2021 PMID: 34106397 PMCID: PMC8188157 DOI: 10.1007/s11739-021-02732-w
Source DB: PubMed Journal: Intern Emerg Med ISSN: 1828-0447 Impact factor: 3.397
Principal personal and Emergency Department presentation features of patients included in the study, by period of observation
| Perioda | |||
|---|---|---|---|
| Control (%) | Pandemic (%) | ||
| Gender | |||
| Male | 5,319 (42.4) | 864 (45.2) | |
| Female | 7,218 (57.6) | 1.047 (54.8) | 0.02 |
| Age class | |||
| < 80 | 3,827 (30.5) | 564 (29.5) | |
| 80–84 | 3,749 (29.9) | 622 (32.5) | |
| 85–89 | 3,115 (24.9) | 458 (24.0) | |
| 90 + | 1,846 (14.7) | 267 (14.0) | 0.14 |
| Transport | |||
| Personal | 4,907 (39.1) | 397 (20.8) | |
| Ambulance | 3,462 (27.6) | 711 (37.2) | |
| MSB | 3,817 (30.5) | 748 (39.1) | |
| MSA | 312 (2.5) | 53 (2.7) | |
| Other | 39 (0.3) | 2 (0.1) | < 0.001 |
| Triage priority | |||
| White code | 318 (2.5) | 32 (1.7) | |
| Green code | 6,033 (48.2) | 807 (42.3) | |
| Yellow-white code | 740 (5.9) | 105 (5.5) | |
| Yellow code | 5,077 (40.5) | 873 (45.7) | |
| Red code | 255 (2.8) | 93 (4.9) | < 0.001 |
| Outcome | |||
| Discharge | 8,051 (64.2) | 804 (42.1) | |
| Hospitalization | 4,085 (32.6) | 1,060 (55.5) | |
| Transfer | 348 (2.8) | 40 (2.1) | |
| Other | 53 (0.4) | 7 (0.4) | < 0.001 |
MSA ambulance with doctor, MSB ambulance with nurse
aThe considered pandemic period spreads from February 21, 2020 to May 1, 2020, while as control period was used the sum of timespan from January 1, 2018 to May 1, 2018, from January 1, 2019 to May 1, 2019 and from January 1, 2020 to February 20, 2020
bχ2 test
Fig. 1Principal features of control and pandemic groups. Data in percentages. The considered pandemic period spreads from February 21, 2020 to May 1, 2020, while as control period was used the sum of timespan from January 1, 2018 to May 1, 2018, from January 1, 2019 to May 1, 2019 and from January 1, 2020 to February 20, 2020.
Principal heart function parameters at presentation for patients include in the study, by period of observation
| Perioda | |||
|---|---|---|---|
| Control | Pandemic | ||
| Heart rate | |||
| Observations | 10,246 | 1,703 | |
| Mean (bpm) | 81.2 | 82.7 | |
| IQR | 70–90 | 70–92 | < 0.001b |
| Heart rate > 110 bpm | |||
| No | 9,517 (75.9%) | 1,557 (81.5%) | |
| Yes | 3,020 (24.1%) | 354 (18.5%) | < 0.001b |
| O2 saturation | |||
| Observations | 10,194 | 1,697 | |
| Mean (%) | 95.9 | 94.9 | |
| IQR | 95–98 | 94–98 | < 0.001b |
| O2 saturation < 95% | |||
| No | 10,125 (80.8%) | 1,359 (71.1%) | |
| Yes | 3,412 (19.2%) | 552 (28.9%) | < 0.001b |
| Systolic blood pressure | |||
| Observations | 10,328 | 1,714 | |
| Mean (mmHg) | 143.0 | 140.7 | |
| IQR | 125–160 | 120–160 | < 0.001b |
| Systolic blood pressure < 90 mmHg | |||
| No | 12,377 (98.4%) | 1,871 (97.9%) | |
| Yes | 200 (1.6%) | 40 (2.1%) | 0.113b |
aThe considered pandemic period spreads from February 21, 2020 to May 1, 2020, while as control period was used the sum of timespan from January 1, 2018 to May 1, 2018, from January 1, 2019 to May 1, 2019 and from January 1, 2020 to February 20, 2020
bMann–Whitney testm, χ2 test
cInterquartile range
Selected time variables accounting for crowding, by period
| Perioda | Observations | Mean | Interquartile range | ||
|---|---|---|---|---|---|
| Wait time (min) | |||||
| Control | 12,536 | 87.4 | 22.2–129.5 | ||
| Pandemic | 1,911 | 62.4 | 12.6–87.4 | < 0.001 | |
| LOSc (min) | |||||
| Control | 12,536 | 472.5 | 166.6–509.5 | ||
| Pandemic | 1,911 | 853.1 | 220.2–1099.6 | < 0.001 | |
| Process time (min) | |||||
| Control | 12,536 | 385.2 | 96.3–405.3 | ||
| Pandemic | 1,911 | 790.7 | 154.3–1012.8 | < 0.001 | |
| Access block total timec (min) | |||||
| Control | 1,775 | 778.2 | 252.5–1053.2 | ||
| Pandemic | 616 | 1200.6 | 341–1434.9 | < 0.001 | |
aThe considered pandemic period spreads from February 21, 2020 to May 1, 2020, while as control period was used the sum of timespan from January 1, 2018 to May 1, 2018, from January 1, 2019 to May 1, 2019 and from January 1, 2020 to February 20, 2020
bMann-Whitney test, calculated only on hospitalized patients
cLOS: Length of stay in emergency department
Fig. 2Effect of pandemic on principal times in ED treatment. Data in minutes The considered pandemic period spreads from February 21, 2020 to May 1, 2020, while as control period was used the sum of timespan from January 1, 2018 to May 1, 2018, from January 1, 2019 to May 1, 2019 and from January 1, 2020 to February 20, 2020.
Risk of overtime for selected time variables accounting for crowding, by period
| Perioda | ORb | 95% confidence interval | |
|---|---|---|---|
| LOS | |||
| Control | 1.00 (Ref.) | – | |
| Pandemic | 2.28 | 2.00–2.60 | < 0.001 |
| Boarding | |||
| Control | 1.00 (Ref.) | – | |
| Pandemic | 2.72 | 2.43–3.06 | < 0.001 |
| Access block | |||
| Control | 1.00 (Ref.) | – | |
| Pandemic | 2.47 | 2.21–2.76 | < 0.001 |
LOS Length Of Stay
aThe considered pandemic period spreads from February 21, 2020 to May 1, 2020, while as control period was used the sum of timespan from January 1, 2018 to May 1, 2018, from January 1, 2019 to May 1, 2019 and from January 1, 2020 to February 20, 2020
bOdds ratios (OR) estimated by multiple regression analysis adjusted by age, gender, priority code at triage, presence of fever or respiratory symptoms and need for moderate-to-high–intensity care
Selected access to Emergency Department causes for patients included in the study, by period of observation
| Perioda | |||
|---|---|---|---|
| Control | Pandemic | ||
| Minor medical issues | |||
| No | 10,767 (85.9%) | 1,709 (89.4%) | |
| Yes | 1,770 (4.1%) | 202 (10.6%) | < 0.001b |
| Minor trauma | |||
| No | 11,359 (90.6%) | 1,791 (93.7%) | |
| Yes | 1,178 (9.4%) | 120 (6.3%) | < 0.001b |
| Major trauma | |||
| No | 12,514 (99.8%) | 1,910 (99.9%) | |
| Yes | 23 (0.2%) | 1 (0.1%) | 0.358c |
| Disease with fever | |||
| No | 12,100 (96.5%) | 1,640 (85.8%) | |
| Yes | 473 (3.5%) | 271 (14.2%) | < 0.001b |
| Respiratory symptoms | |||
| No | 10,668 (85.1%) | 1,550 (81.1%) | |
| Yes | 1,869 (14.9%) | 361 (18.9%) | < 0.001b |
| Thoracic pain | |||
| No | 11,520 (91.9%) | 1,769 (92.6%) | |
| Yes | 1,017 (8.1%) | 142 (7.4%) | 0.307b |
| Neurologic disease | |||
| No | 11,249 (89.7%) | 1,673 (87.6%) | |
| Yes | 1,288 (10.3%) | 238 (12.4%) | 0.004b |
aThe considered pandemic period spreads from February 21, 2020 to May 1, 2020, while as control period was used the sum of timespan from January 1, 2018 to May 1, 2018, from January 1, 2019 to May 1, 2019 and from January 1, 2020 to February 20, 2020
bχ2 test,
cFisher test